Progress in Mind
Your Psychiatry and Neurology online resource center
Choose a channel
Check out the different Progress in Mind content channels.
Mental health
Congress highlights
Beyond the guidelines: Precision Medicine
Despite the attractiveness of precision medicine (PM) for providing personalized patient management...
Mental health
Congress highlights
What is the role of inflammation in the pathophysiology of mood disorders?
Evidence supporting a role for inflammation and pro-inflammatory mediators in the pathophysiology...
Mental health
Congress highlights
A public invitation to view and comment on pre-final APA schizophrenia guideline statements
Many guidelines exist worldwide on how best to manage psychiatric illnesses, but we never see two...
Schizophrenia
Congress highlights
Adherence in the real world
Non-adherence and lack of engagement commonly mean that patients with serious mental illnesses may...
Mental health
Congress highlights
Challenges for social psychiatry in a changing world
Modern social risk factors for the development of severe psychiatric disorders, such as migration...
Depression, Schizophrenia
Congress highlights
Lifestyle, the gut, and mental health
Interventions to lower the risk for cardiovascular disease and metabolic syndrome, correction of...
Mental health
Congress highlights
Social isolation and stigma: Cross-cultural perspectives
Meaningful connection to other people is as essential to health as the air we breathe. So the...
Schizophrenia
Congress highlights
Negative symptoms – the motivational conundrum
How to improve motivation when engaging in motivational improvement exercises requires a high level...
Schizophrenia
Congress highlights
Neuroimaging, antipsychotics and registries – functional capacity
Neuroimaging studies of response to antipsychotic therapies and glutamate levels in first-episode...
Schizophrenia
Congress highlights
Enhancing neuroimaging genetics – What do we really see?
Enhancing neuroimaging genetics through meta-analysis (ENIGMA) does exactly what its expanded...
Schizophrenia
Congress highlights
Ethics of psychosis prevention – Could we? Should we?
The SIRS Ethics Committee inaugurated the first of its annual symposia at SIRS 2019 to discuss the...
Schizophrenia
Congress highlights
Long-acting injectables – functioning and compliance studies
Two posters presented during SIRS 2019 suggest that use of long-acting injectable (LAI)...
Featured articles
THINC®
Depression
Seminar
THINC® Online Course
Depression - 29.03.2016
Download
Download the THINC-it® Tool
Depression
Download
THINC-it® physician guide
The THINC-it® user guide is now available and can be downloaded here.
Depression
Interview
THINC-it® tool has now been validated! Its importance for measurement-based care in depression
Depression
Article
THINC-it® cognition screening tool now clinically validated
Depression
Article
Infographic for the health care provider describing THINC-it® as a simple, quick and effective way to screen for cognitive dysfunction in depression
Depression
Article
THINC-it® participant leaflet now available
Recommended videos
Video
Two sides of the same coin
7m:19s
Interview
Professor James MacCabe defines Treatment Resistance Schizophrenia
3m:27s
Video
Professor Mark Opler - Teaming up with patients
9m:09s
Video
Improvement in schizophrenia: Long and short term perspectives
5m:39s
Interview
John FP Bridges – Priorities of people living with SCZ
3m:39s
Video
Better understanding of depression, its symptoms and treatment, is needed
3m:39s
Interview
Control of side effects may be the key to solving the dopamine paradox of schizophrenia
3m:44s
Video
Expert insight: on residual and cognitive symptoms in MDD
Interview
John FP Bridges - Aiming for recovery: the world before Schizophrenia
4m:21s
Most popular on Progress in Mind
Depression, Schizophrenia
Article
ICD-11 – fielding for diagnostic success
In 2018, the World Health Organization (WHO) will release two important documents, both of which should aid for the better diagnosis of mental illness; the newer
Depression
Congress highlights
When to change first-line treatment: Debating an everyday dilemma
Schizophrenia
Congress highlights
Mapping of early intervention programs for psychosis in France
Schizophrenia
Congress highlights
Dopamine D2 partial agonists – efficacy, tolerability and improved functioning?
Parkinson's Disease
Congress highlights
Getting rid of alpha-synuclein – active and passive immunotherapy, or maybe targeting LRRK2?
Alzheimer's Disease
Article
Advances in the early diagnosis of Alzheimer’s Disease
Article